WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy

Seyed Vahid Tabatabaei; Seyed Moayed Alavian; Maryam Keshvari; Bita Behnava; Seyyed Mohammad Miri; Pegah Karimi Elizee; Farhad Zamani; Sedigheh Amini Kafi-Abad; Ahmad Gharehbaghian; Bashir Hajibeigy; Kamran Bagheri Lankarani

doi:10.1016/j.jhep.2010.10.026

WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy

J Hepatol. 2010 Nov 23. doi: 10.1016/j.jhep.2010.10.026. Online ahead of print.

Authors

Seyed Vahid Tabatabaei¹, Seyed Moayed Alavian, Maryam Keshvari, Bita Behnava, Seyyed Mohammad Miri, Pegah Karimi Elizee, Farhad Zamani, Sedigheh Amini Kafi-Abad, Ahmad Gharehbaghian, Bashir Hajibeigy, Kamran Bagheri Lankarani

Affiliation

¹ Baqiyatallah University of Medical Sciences, Baqiyatallah Research Center for Gastroenterology and Liver Disease, Tehran, Iran.

PMID: 21145858
DOI: 10.1016/j.jhep.2010.10.026

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.